TY - JOUR
T1 - Predictive factors for disease recurrence in patients with locally advanced renal cell carcinoma treated with curative surgery
AU - Chang, Te Wei
AU - Cheng, Wei Ming
AU - Fan, Yu Hua
AU - Lin, Chih Chieh
AU - Lin, Tzu Ping
AU - Huang, Eric Yi Hsiu
AU - Chung, Hsiao Jen
AU - Huang, William J.S.
AU - Weng, Shih Han
N1 - Publisher Copyright:
Copyright © 2021, the Chinese Medical Association.
PY - 2021/4/1
Y1 - 2021/4/1
N2 - Background: Few prognostic factors have been proposed for patients with locally advanced renal cell carcinoma (RCC). This study aimed to investigate the possible predictive factors for disease-free survival (DFS) after curative surgery for RCC stage T3 or higher. Methods: Patients with locally advanced RCC who underwent cure-intended partial or radical nephrectomy, with or without tumor thrombectomy, at our institution from April 1, 2005 to October 31, 2013 were retrospectively reviewed. Those undergoing cytoreductive nephrectomy were excluded. Preoperative data, including surgical and pathologic characteristics, were assessed for correlation with DFS. Chi-square tests, univariate and multivariate Cox regression analysis, and Kaplan–Meier survival curve analyses were performed to determine potential predictive factors. A p value less than 0.05 was considered statistically significant. Results: A total of 159 patients were included for analysis. The mean duration of follow-up was 37.9 months, and 119 (74.8%) patients remained disease-free during follow-up. Disease recurrence was found in 40 (25.2%) patients, and pathologic T stage, capsule penetration, Fuhrman grade, thrombocytosis, renal vein thrombosis, and elevated serum alkaline phosphatase, platelet/ lymphocyte ratio, and γ-glutamyl transpeptidase levels were significantly associated with disease recurrence on univariate analysis. On multivariate analysis, Fuhrman grade 3 or 4 (HR = 5.70, p = 0.0003, 95% CI = 2.23–14.56) showed significant associations with DFS. Conclusion: In patients with locally advanced RCC, Fuhrman grade was associated with worse DFS after curative surgery. Urologists should closely monitor patients with high Fuhrman grades.
AB - Background: Few prognostic factors have been proposed for patients with locally advanced renal cell carcinoma (RCC). This study aimed to investigate the possible predictive factors for disease-free survival (DFS) after curative surgery for RCC stage T3 or higher. Methods: Patients with locally advanced RCC who underwent cure-intended partial or radical nephrectomy, with or without tumor thrombectomy, at our institution from April 1, 2005 to October 31, 2013 were retrospectively reviewed. Those undergoing cytoreductive nephrectomy were excluded. Preoperative data, including surgical and pathologic characteristics, were assessed for correlation with DFS. Chi-square tests, univariate and multivariate Cox regression analysis, and Kaplan–Meier survival curve analyses were performed to determine potential predictive factors. A p value less than 0.05 was considered statistically significant. Results: A total of 159 patients were included for analysis. The mean duration of follow-up was 37.9 months, and 119 (74.8%) patients remained disease-free during follow-up. Disease recurrence was found in 40 (25.2%) patients, and pathologic T stage, capsule penetration, Fuhrman grade, thrombocytosis, renal vein thrombosis, and elevated serum alkaline phosphatase, platelet/ lymphocyte ratio, and γ-glutamyl transpeptidase levels were significantly associated with disease recurrence on univariate analysis. On multivariate analysis, Fuhrman grade 3 or 4 (HR = 5.70, p = 0.0003, 95% CI = 2.23–14.56) showed significant associations with DFS. Conclusion: In patients with locally advanced RCC, Fuhrman grade was associated with worse DFS after curative surgery. Urologists should closely monitor patients with high Fuhrman grades.
KW - Disease-free survival
KW - Fuhrman grade
KW - Prognosis
KW - Renal cell carcinoma
UR - http://www.scopus.com/inward/record.url?scp=85103682866&partnerID=8YFLogxK
U2 - 10.1097/JCMA.0000000000000501
DO - 10.1097/JCMA.0000000000000501
M3 - Article
C2 - 33595988
AN - SCOPUS:85103682866
SN - 1726-4901
VL - 84
SP - 405
EP - 409
JO - Journal of the Chinese Medical Association
JF - Journal of the Chinese Medical Association
IS - 4
ER -